An elderly patient who completed oral cephalexin for lower extremity cellulitis now has a swollen, markedly erythematous limb. What is the appropriate intravenous antibiotic regimen, including dose and duration?

IV Antibiotic Regimen for Failed Oral Cellulitis Treatment

For an elderly patient with worsening lower extremity cellulitis after completing oral cephalexin, initiate IV cefazolin 1-2 g every 8 hours or vancomycin 30 mg/kg/day divided every 12 hours (if MRSA suspected), continuing until clinical improvement (typically 5-10 days total duration), then transition to oral therapy to complete 7-14 days total treatment.

Initial Assessment and Risk Stratification

The clinical worsening despite completed oral therapy signals either:

• Inadequate initial antibiotic coverage (possible MRSA)
• Insufficient drug levels from oral therapy
• Complicated infection requiring parenteral therapy
• Misdiagnosis (consider necrotizing infection, abscess, DVT)

Critical red flags requiring immediate surgical consultation: systemic toxicity (fever, hypotension, tachycardia >90, WBC >12,000 or <4,000), rapidly progressive erythema, skin necrosis, crepitus, or severe pain disproportionate to exam 1.

Empiric IV Antibiotic Selection

For Non-Purulent Cellulitis (Most Likely Scenario)

First-line options 1:

• Cefazolin 1 g every 8 hours IV - Covers streptococci and MSSA, preferred for penicillin-allergic patients without immediate hypersensitivity
• Nafcillin or oxacillin 1-2 g every 4 hours IV - Parenteral drug of choice for MSSA
• Clindamycin 600-900 mg every 8 hours IV - Alternative if beta-lactam allergy

If MRSA Suspected (Add if):

• Previous MRSA infection
• Failed initial beta-lactam therapy (as in this case)
• Purulent drainage present
• Local MRSA prevalence >10-30%

MRSA coverage 1:

• Vancomycin 30 mg/kg/day in 2 divided doses IV (15 mg/kg every 12 hours) - Parenteral drug of choice
• Linezolid 600 mg every 12 hours IV - Alternative, can transition to oral
• Daptomycin 4 mg/kg every 24 hours IV - Bactericidal option

Practical Dosing Approach

Most practical regimen for elderly patient with treatment failure:

1. Start vancomycin 15 mg/kg IV every 12 hours (adjust for renal function) PLUS cefazolin 1 g IV every 8 hours to cover both MRSA and streptococci until cultures available 1

2. Alternative monotherapy if MRSA unlikely: Cefazolin 2 g IV every 8-12 hours 2, 3 - Real-world data shows 2 g twice daily is highly effective (84.7% success rate) 2

Duration of IV Therapy

IV therapy duration: Continue until clinical improvement is evident 1:

• Reduction in erythema, warmth, and swelling
• Afebrile for 24-48 hours
• Typically 5-10 days IV therapy based on severity 4

Factors prolonging IV duration in elderly 4:

• Advanced age (independently associated with longer treatment)
• Elevated CRP before treatment
• Diabetes mellitus (significantly longer duration needed)
• Concurrent bacteremia
• Immunosuppression

Total antibiotic duration: 7-14 days total (IV + oral) 1, 5. Recent data suggests 6-7 days may be adequate for uncomplicated cases, but given treatment failure, aim for 10-14 days total 5.

Transition to Oral Therapy

Once improved (reduced erythema, afebrile 24-48 hours), transition to oral:

For MSSA/Streptococcal infection:

• Cephalexin 500 mg QID or 1000 mg TID 6, 7
• Dicloxacillin 500 mg QID

For MRSA:

• Linezolid 600 mg BID
• Trimethoprim-sulfamethoxazole 1-2 double-strength tablets BID
• Doxycycline 100 mg BID

Critical Pitfalls to Avoid

1. Underdosing in elderly/obese patients: Standard cephalexin 500 mg QID may be inadequate for moderate-severe SSTI, especially in obesity 7. Consider higher doses (1000 mg TID-QID) for moderate-severe infections.

2. Missing necrotizing infection: If patient has severe systemic toxicity, obtain urgent surgical consultation and start broad-spectrum coverage (vancomycin PLUS piperacillin-tazobactam 3.375 g every 6 hours or carbapenem) 1.

3. Ignoring predisposing factors: Address lymphedema, venous insufficiency, tinea pedis, obesity - these perpetuate recurrence 1.

4. Premature oral switch: Ensure 24-48 hours of clinical improvement before transitioning. In elderly with diabetes or bacteremia, may need longer IV course 4.

5. Inadequate follow-up: Elderly patients with treatment failure need close monitoring (48-72 hours) to ensure response 8.

Special Considerations for Elderly

• Renal dose adjustment: Vancomycin and cefazolin require adjustment for CrCl <50 mL/min
• Monitor for linezolid toxicity: If used >2 weeks, risk of lactic acidosis and cytopenias increases 9
• Consider home IV therapy: If stable, cefazolin 2 g IV BID with probenecid 1 g daily allows outpatient management 2, 3

The evidence strongly supports aggressive IV therapy in this scenario given treatment failure, with vancomycin plus cefazolin providing optimal empiric coverage until pathogen identification guides definitive therapy 1.